'Brand new way to treat patients': Ketamine injections approved for Alberta's community facilities
The regulatory body for Alberta doctors has recently updated its regulations allowing non-hospital treatment centres to administer Ketamine to treat serious depression and mental health conditions.
The College of Physicians and Surgeons of Alberta (CPSA) now approves community facilities with in-house anesthesiologists and psychiatrists to offer the dissociative or sedative psychedelic via IV (intravenous).
The Ketatmine-assisted therapy can also be used to manage chronic pain disorders.
"I'm really excited to be on this new frontier, and a brand new way to treat patients," said Dr. Craig Pearce, president of anesthesia for the Alberta Medical Association, and medical director at SABI Mind, a private psychedelic therapy clinic.
Pearce said his best friend died by suicide 27 years ago, and says his work in his new role is driven by a desire to help others who may be experiencing extreme distress.
"If this is an opportunity for me to help rescue and save someone else who has that type of affliction or concern and improve their life, then I'm going to jump at it," said Pearce.
Andrea Daye says she's suffered with depression on and off since she was 16, and underwent Ketamine treatments from June to last August.
"I feel amazing today. Mental health is a journey that goes up and down and zig-zags, but the Ketamine really helped," she said.
Daye said she is no longer an intensive care unit nurse, after suffering from traumatic experiences in a Calgary area hospital during COVID-19 waves in 2021.
She says maintaining her mental health is ongoing, but the therapy helped her find her way out of a major depressive episode last May.
"It is a catalyst and an extremely effective catalyst, more effective than anything I have ever done before," said Daye.
Psychedelic therapy for mood disorders and chronic pain is an emerging field of study, as researchers hope to determine if controlled substances help "treatment-resistant" patients whose conditions don't show improvement with traditional pharmaceuticals or therapies.
"What is it that's really driving these effects? Is it the drugs that are being used or the context in which they're being given? That's what we're really interested in, is really distilling it down to what is the important ingredient that we need to look for," said Dr. Leah Mayo, Parker Psychedelics research chair at University of Calgary.
Mayo says government-funded research will help find answers to questions about the efficacy of psychedelics.
The Centre for Addiction and Mental Health (CAMH) has launched a study through a federal grant to explore how Psilocybin (the chemical in “magic mushrooms") can treat depression and if the hallucinogenic or psychedelic effects are necessary.
"There's a lot that we still don't know about the use of psychedelic drugs and how they actually help people with mental health conditions," said Dr. Ishrat Husain, head of clinical trails at CAMH.
He added, "It may well be in fact that it is the hallucinogenic experience that sort of leads to access to repressed memories and opens up the brain to be more receptive to psychotherapy."
Husain said if the study demonstrates the ingredients can work even without inducing a psychedelic effect it would be easier to put into practise -- saving time, resources and costs.
He says a "trip" can range up to eight hours, and requires medical supervision.
The clinical trial includes 60 adult participants with treatment-resistant depression and will run over a three-year period.
For Dr. Mayo in Calgary, expanded science and research would help provide broader access to effective alternative treatments.
"The people who need these treatments right now, people with really severe mental health conditions might not be able to go to these Ketamine clinics that are available and pay the fees that are associated with it," said Mayo.
At the moment, Ketamine therapy is the only psychedelic approved and regulated in Canada for specific conditions.
There are no therapeutic products containing psilocybin, LSD, MDMA or DMT approved for sale in Canada outside of a clinical trial.
CTVNews.ca Top Stories
DEVELOPING Man sets self on fire outside New York court where Trump trial underway
A man set himself on fire on Friday outside the New York courthouse where Donald Trump's historic hush-money trial was taking place as jury selection wrapped up, but officials said he did not appear to have been targeting Trump.
BREAKING Sask. father found guilty of withholding daughter to prevent her from getting COVID-19 vaccine
Michael Gordon Jackson, a Saskatchewan man accused of abducting his daughter to prevent her from getting a COVID-19 vaccine, has been found guilty for contravention of a custody order.
She set out to find a husband in a year. Then she matched with a guy on a dating app on the other side of the world
Scottish comedian Samantha Hannah was working on a comedy show about finding a husband when Toby Hunter came into her life. What happened next surprised them both.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.
'It could be catastrophic': Woman says natural supplement contained hidden painkiller drug
A Manitoba woman thought she found a miracle natural supplement, but said a hidden ingredient wreaked havoc on her health.
Young people 'tortured' if stolen vehicle operations fail, Montreal police tell MPs
One day after a Montreal police officer fired gunshots at a suspect in a stolen vehicle, senior officers were telling parliamentarians that organized crime groups are recruiting people as young as 15 in the city to steal cars so that they can be shipped overseas.
The Body Shop Canada explores sale as demand outpaces inventory: court filing
The Body Shop Canada is exploring a sale as it struggles to get its hands on enough inventory to keep up with "robust" sales after announcing it would file for creditor protection and close 33 stores.
Vicious attack on a dog ends with charges for northern Ont. suspect
Police in Sault Ste. Marie charged a 22-year-old man with animal cruelty following an attack on a dog Thursday morning.
On federal budget, Macklem says 'fiscal track has not changed significantly'
Bank of Canada governor Tiff Macklem says Canada's fiscal position has 'not changed significantly' following the release of the federal government's budget.